Biotech Values

[DewDiligence]

Re: Campath article and table from Nature Biotechnology

The table at the end of the article has an error: Cladribine is sponsored by Merck Serono (Germany), not Merck & Co. (NJ, USA) as shown in the table.

(The table in #msg-31519342 has this right; however, it omits the drugs from ACOR, BioMS, and Accentia. The latter is in bankruptcy, so perhaps the omission is warranted!)

Moreover, I have a problem with this assertion from the Nature article:

Still in the game, but just barely, is Basel–based Novartis' S1P1 modulator FTY720 (fingolimod)…

What a crock! FTY720 is more than barely in the game.